Title 21 › CHAPTER 9 — FEDERAL FOOD, DRUG, AND COSMETIC ACT › SUBCHAPTER VII — GENERAL AUTHORITY › Part D — Information and Education › § 379k–1
Certain drug and biological product filings must be given in an electronic format the Secretary sets out. That change can begin no earlier than 24 months after the Secretary issues final guidance following public notice and comment. The guidance can give a schedule for more detailed electronic rules and explain when waivers or exemptions are allowed. This rule does not apply to filings covered by section 360bbb. For medical devices, after the Secretary issues final guidance, pre‑submissions, submissions, and any supplements for certain device laws must include an electronic copy. The guidance can set the standards for that copy and rules for waivers. Later, on a date the Secretary names in final guidance, those device filings (and related appeals) must be submitted only in the specified electronic format. The Secretary was to issue draft guidance by October 1, 2019, and final guidance within 1 year after the public comment period on that draft closed.
Full Legal Text
Food and Drugs, Source: USLM XML via OLRC
Legislative History
Reference
Citation
21 U.S.C. § 379k–1
Title 21, Food and Drugs
Last Updated
Sep 22, 2026
Release point: 119-110